The meteoric rise of Palantir Technologies Inc. throughout the year is undeniable, but a significant challenge has now emerged. Michael Burry, the famed investor immortalized in “The Big Short,” has placed a massive bet against the artificial intelligence leader. His firm has established a short position valued at hundreds of millions of dollars, anticipating a substantial decline in the share price. This bearish stance, however, is being directly countered by a surprising and confident move from Palantir’s own Chief Executive Officer, Alex Karp. The financial markets are now watching closely to see which of these powerful figures will prevail in this high-stakes confrontation.
CEO Confidence Confronts the Bears
From the company’s leadership comes a powerful signal intended to bolster investor confidence. Alex Karp has decided to terminate his pre-arranged stock trading plan, known as a 10b5-1 plan. Historically, executives use these plans to systematically sell shares. By halting his automatic sales instead of renewing the program, Karp is sending a strong message to the market. This action demonstrates a belief within the upper management that the company’s stock possesses further upside potential, while simultaneously removing a source of consistent selling pressure that often weighs on a share price.
This vote of confidence from the top is supported by robust operational performance. The company’s most recent quarterly earnings surpassed market expectations. A particularly stunning figure was the 121 percent explosion in commercial revenue within the United States, a surge largely credited to the rapid adoption of its proprietary Artificial Intelligence Platform (AIP).
The Valuation Concern Driving the Short Bet
The primary catalyst for Michael Burry’s substantial bearish wager is a fundamental concern over valuation. Scion Asset Management, his investment firm, has disclosed put options against Palantir with a notional value of $900 million. The core of this investment thesis hinges on the belief that the stock has become excessively overvalued.
Should investors sell immediately? Or is it worth buying Palantir?
To conservative investors, the metrics are indeed startling. The stock trades at a price-to-earnings multiple approaching 400 and a price-to-sales multiple exceeding 60. Burry is effectively betting that the current market euphoria will dissipate, forcing a sharp correction that realigns the share price with its fundamental financials. Market action already reflects this tension; the stock has retreated approximately 20 percent from its 52-week high of around 180 Euros.
Strategic Wins and Government Uncertainties
Beyond the stock market battle, Palantir’s business landscape presents a mixed picture. In Europe, the company secured a monumental strategic partnership with the UK Ministry of Defence. This agreement paves the way for investments that could reach up to £1.5 billion over the coming decade, representing a huge vote of confidence and a significant revenue stream.
Conversely, in its key domestic market, a cloud of uncertainty has formed. The Pentagon has initiated a review of its software budgeting, which includes the potential for reallocating funds. While Palantir has not been explicitly singled out, this situation creates nervousness among institutional investors. The competition for lucrative government contracts between established defense contractors and disruptive AI-focused firms like Palantir introduces a element of short-term risk.
The Palantir stock narrative has become a classic battleground, pitting fears of an inflated valuation against aggressive growth expectations. The central question for investors is whether the demonstrative confidence from CEO Alex Karp will be enough to stabilize and rally the shares, or if Michael Burry’s pessimistic outlook will ultimately triumph.
Ad
Palantir Stock: Buy or Sell?! New Palantir Analysis from November 30 delivers the answer:
The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 30.
Palantir: Buy or sell? Read more here...









